Exploring glycopentamides from Glycosmis pentaphylla as CDK4 inhibitors: a computational study

Binh Le Doan Thao Phuong Tran Anh Trâm Nguyễn P. Pham N. T. T. Giang H. Nguyen Ha Xuan Nguyen Thuy Thi Phan

Sep 2026 · Journal of the Iranian Chemical Society · Vol 23 · 0 citations · 49 references

TL;DR

Findings identify glycopentamide B as the most promising CDK4-binding candidate among the investigated compounds and support its further evaluation as a potential anticancer lead.

DOI Semantic Scholar

View source

Similar papers

Oct 2026

Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds.

Structural, conformational, energetic, and pharmacokinetic characterization of dutasteride, danazol, and azelastine as candidate CDK6-binding scaffolds are provided.

Syarifuddin Husain, Ruzianisra Mohamed, Khairul Bariyyah Abd. Halim et al. · Journal of Molecular Graphic... · 0 citations

Aug 2026

Discovery of Potent CDK2 Inhibitors Through Structure-Based Virtual Screening and MD Simulation Studies.

Overall, MD1-MD5 demonstrated excellent binding, structural stability, and pharmacokinetic properties, making them strong candidates for future CDK2-targeted anticancer research.

Dharmesh A. Patel, Apurva Prajapati, Siddharth S. Patel et al. · Biotechnology and applied bi... · 0 citations

Open access Sep 2026

Computational Evaluation of Carbazole–Chalcone Urea and Thiourea Derivatives Against EGFR: Molecular Docking, Pharmacokinetic Profiling, Target Prediction, and Molecular Dynamics Simulation

Overall, 5f was computationally prioritized based on its favorable predicted EGFR interactions and sustained association over the investigated simulation timescale, while its physicochemical and pharmacokinetic limitations indicate the need for further structural optimization and experimental validation.

Arleta Rifati-Nixha, Mustafa Arslan, M. Dërmaku-Sopjani et al. · Molecules · 0 citations

Aug 2026

Structure-based discovery of diphenylpyrazines as disruptors of the Skp2–Cks1 protein–protein interaction: computational insights and biochemical validation

Findings validate the diphenylpyrazine scaffold as a promising chemotype for Skp2–Cks1 inhibition and identify C3 as a strong lead for further optimization.

Emadeldin M. Kamel, A. A. Allam, H. Rudayni et al. · Journal of Computer-Aided Mo... · 0 citations

Open access Aug 2026

In silico exploration of Qur’anic-based natural products as potential anticancer BRAF inhibitors via structure-based virtual screening

This study aimed to identify novel BRAF V600E inhibitors through an in silico evaluation of the binding affinity and ADMET safety profile of bioactive compounds from 32 Qurʼanic natural product plants, utilizing a structure-based virtual screening of 2,308 compounds.

Evita Sari, G. Nugraha, D. Saputra · JURNAL ILMU KEFARMASIAN INDO... · 0 citations

Open access Sep 2026

Investigation of ABL Kinase Inhibitory Potential of Bioactive From Juglans Regia: Molecular Docking, Pharmacophore Modelling and Molecular Dynamics Simulation Study

Investigation of phytoconstituents of Juglans regia derived from IMPPAT database as inhibitors of the Abelson tyrosine kinase, identifies plumbagin as a candidate for c-Abl kinase inhibitor.

Z. Fathima C., J. James, Sindhu T. J. et al. · International Journal of App... · 0 citations